Prevention of Relapse to Opioid Addiction Using Depot Naltrexone.
Phase of Trial: Phase II/III
Latest Information Update: 20 Sep 2016
At a glance
- Drugs Naltrexone (Primary)
- Indications Opioid abuse
- Focus Therapeutic Use
- 31 Mar 2016 Status changed from active, no longer recruiting to completed, according to results published in the New England Journal of Medicine.
- 31 Mar 2016 Primary endpoint of the time (in weeks) to an opioid-relapse event during the 24-week treatment phase has been met, according to results published in the New England Journal of Medicine
- 31 Mar 2016 Results published in the New England Journal of Medicine